204 related articles for article (PubMed ID: 25051021)
1. Impact of histological variants on the outcomes of nonmuscle invasive bladder cancer after transurethral resection.
Seisen T; Compérat E; Léon P; Roupret M
Curr Opin Urol; 2014 Sep; 24(5):524-31. PubMed ID: 25051021
[TBL] [Abstract][Full Text] [Related]
2. Variant histology: role in management and prognosis of nonmuscle invasive bladder cancer.
Porten SP; Willis D; Kamat AM
Curr Opin Urol; 2014 Sep; 24(5):517-23. PubMed ID: 24921905
[TBL] [Abstract][Full Text] [Related]
3. Does presence of squamous and glandular differentiation in urothelial carcinoma of the bladder at cystectomy portend poor prognosis? An intensive case-control analysis.
Mitra AP; Bartsch CC; Bartsch G; Miranda G; Skinner EC; Daneshmand S
Urol Oncol; 2014 Feb; 32(2):117-27. PubMed ID: 23477878
[TBL] [Abstract][Full Text] [Related]
4. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
Solsona E; Iborra I; Rubio J; Casanova J; Almenar S
BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101
[TBL] [Abstract][Full Text] [Related]
5. [Bladder preservation or initial cystectomy in T1G3 bladder cancer: which parameters help in therapeutic decision-making?].
Denzinger S; Burger M; Fritsche HM; Ganzer R; Blana A; Wieland WF; Otto W
Aktuelle Urol; 2008 Jan; 39(1):58-61; discussion 62-3. PubMed ID: 18228189
[TBL] [Abstract][Full Text] [Related]
6. Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy.
Xylinas E; Rink M; Robinson BD; Lotan Y; Babjuk M; Brisuda A; Green DA; Kluth LA; Pycha A; Fradet Y; Faison T; Lee RK; Karakiewicz PI; Zerbib M; Scherr DS; Shariat SF
Eur J Cancer; 2013 May; 49(8):1889-97. PubMed ID: 23466126
[TBL] [Abstract][Full Text] [Related]
7. [Cost-effectiveness of transurethral resection of the bladder with blue light in patients with non muscle invasive bladder cancer in France].
Rouprêt M; Malavaud B; Molinier L; Leleu H; Blachier M; Marteau F
Prog Urol; 2015 Apr; 25(5):256-64. PubMed ID: 25605343
[TBL] [Abstract][Full Text] [Related]
8. Accuracy of Transurethral Resection of the Bladder in Detecting Variant Histology of Bladder Cancer Compared with Radical Cystectomy.
Lonati C; Baumeister P; Ornaghi PI; Di Trapani E; De Cobelli O; Rink M; Karnes RJ; Poyet C; Simone G; Afferi L; Necchi A; Briganti A; Montorsi F; Krajewski W; Antonelli A; Cerruto MA; Zamboni S; Simeone C; Mordasini L; Mattei A; Moschini M;
Eur Urol Focus; 2022 Mar; 8(2):457-464. PubMed ID: 33867307
[TBL] [Abstract][Full Text] [Related]
9. [Prostatic involvement by urothelial carcinoma in patients with bladder cancer and their implications in the clinical practice].
Huguet J
Actas Urol Esp; 2012 Oct; 36(9):545-53. PubMed ID: 22520044
[TBL] [Abstract][Full Text] [Related]
10. Obesity is associated with worse outcomes in patients with T1 high grade urothelial carcinoma of the bladder.
Kluth LA; Xylinas E; Crivelli JJ; Passoni N; Comploj E; Pycha A; Chrystal J; Sun M; Karakiewicz PI; Gontero P; Lotan Y; Chun FK; Fisch M; Scherr DS; Shariat SF
J Urol; 2013 Aug; 190(2):480-6. PubMed ID: 23376707
[TBL] [Abstract][Full Text] [Related]
11. Recurrence and progression of T1G3 transitional cell carcinoma of the bladder treated with intravesical bacillus Calmette-Guérin.
Günlüsoy B; Değirmenci T; Arslan M; Nergiz N; Minareci S; Ayder AR
Urol Int; 2005; 75(2):107-13. PubMed ID: 16123562
[TBL] [Abstract][Full Text] [Related]
12. [Your patient with carcinoma of the urinary bladder. Options for organ preservation].
Zaak D
MMW Fortschr Med; 2003 Jan; 145(5):28-32. PubMed ID: 12619205
[TBL] [Abstract][Full Text] [Related]
13. [A case of transitional cell carcinoma with squamous differentiation which developed squamous cell carcinoma in situ in the clinical course].
Sugiura S; Makiyama K; Yokomizo Y; Umemoto S; Miyoshi Y; Nakaigawa N; Ogawa T; Uemurai H; Yao M; Kubota Y; Yamanaka S
Hinyokika Kiyo; 2006 Sep; 52(9):715-8. PubMed ID: 17040058
[TBL] [Abstract][Full Text] [Related]
14. Prognostic interest in discriminating muscularis mucosa invasion (T1a vs T1b) in nonmuscle invasive bladder carcinoma: French national multicenter study with central pathology review.
Rouprêt M; Seisen T; Compérat E; Larré S; Mazerolles C; Gobet F; Fetissof F; Fromont G; Safsaf A; d'Arcier BF; Celhay O; Validire P; Rozet F; Irani J; Soulié M; Pfister C;
J Urol; 2013 Jun; 189(6):2069-76. PubMed ID: 23201497
[TBL] [Abstract][Full Text] [Related]
15. [Radical cystectomy in patients with non-muscle invasive bladder cancer who fail BCG therapy].
Huguet J; Gaya JM; Sabaté S; Palou J; Villavicencio H
Actas Urol Esp; 2010 Jan; 34(1):63-70. PubMed ID: 20223134
[TBL] [Abstract][Full Text] [Related]
16. New agents for bacillus Calmette-Guérin-refractory nonmuscle invasive bladder cancer.
Ahn JJ; Ghandour RA; McKiernan JM
Curr Opin Urol; 2014 Sep; 24(5):540-5. PubMed ID: 24921906
[TBL] [Abstract][Full Text] [Related]
17. Follow-up of nonmuscle invasive transitional cell carcinoma of the bladder: how and how often?
Schmidbauer J; Lindenau G
Curr Opin Urol; 2008 Sep; 18(5):504-7. PubMed ID: 18670275
[TBL] [Abstract][Full Text] [Related]
18. Invasive T1 bladder cancer: indications and rationale for radical cystectomy.
Stein JP; Penson DF
BJU Int; 2008 Aug; 102(3):270-5. PubMed ID: 18494831
[TBL] [Abstract][Full Text] [Related]
19. Inguinal metastasis of a bladder mixed carcinoma with predominant adenocarcinoma component.
Hamano A; Udagawa K; Nomura S; Ishida T
Scand J Urol Nephrol; 2006; 40(1):75-7. PubMed ID: 16452061
[TBL] [Abstract][Full Text] [Related]
20. Is transurethral resection alone enough for the diagnosis of histological variants? A single-center study.
Moschini M; Shariat SF; Freschi M; Soria F; D'Andrea D; Abufaraj M; Foerster B; Dell'Oglio P; Zaffuto E; Mattei A; Salonia A; Montorsi F; Briganti A; Gallina A; Colombo R
Urol Oncol; 2017 Aug; 35(8):528.e1-528.e5. PubMed ID: 28433471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
